Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma
By: Cabibi D, Calascibetta A, Aragona F, Martorana A, Campione M, Sanguedolce R.

Dipartimento di Scienze Farmacologiche, Policlinico Via del Vespro, Palermo, Italy.
Anticancer Res. 2009 Nov;29(11):4417−22.

Abstract

Background

Pure signet−ring cell colorectal carcinoma (SRCC) is an infrequent and highly malignant histological variant of colorectal cancer (CRC), while it is present as a histological component in colorectal carcinomas more frequently.

Materials And Methods

The aim of this work was to widen the knowledge of the biological factors involved in the pathogenesis and aggressiveness of SRCC by the identification and evaluation of possible molecular abnormalities. By means of immunohistochemistry the expression of the proteolytic degradation enzyme matrix metalloprotease (MMP)−1, that is a collagenase specifically degrading collagens I, II, III and of the adhesion proteins E−cadherin, beta−catenin and fibronectin which are usually involved in the carcinogenesis of conventional colorectal tumours was investigated.

Results

SRCCs showed a significantly greater MMP−1 expression compared to the ordinary intestinal colorectal cancer (ICRC) and a significantly reduced E−cadherin, beta−catenin and fibronectin expression.

Conclusion

The biological aggressiveness and strong metastatic behaviour of SRCC could be due to high MMP−1 and low expression of the adhesion molecules.

PMID: 20032387 [PubMed − indexed for MEDLINE] Source: National Library of Medicine.






* Albert Einstein College of Medicine has been
awarded Acceditation with Commendation by
the ACCME

Copyright 2025 InterMDnet | Privacy Policy | Disclaimer | System Requirements